MINJUNG REGER: Open Payments
NPI 1659813632 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,148 in 99 payments from 21 companies in 2025. Trend: 2023 $1,721 · 2024 $1,657 · 2025 $2,148
Food & beverage: $2,049Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $369 |
| Regeneron Healthcare Solutions, Inc. | 7 | $280 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $261 |
| ABBVIE INC. | 12 | $182 |
| Incyte Corporation | 6 | $155 |
| Organon LLC | 9 | $141 |
| GENZYME CORPORATION | 5 | $124 |
| Lilly USA, LLC | 6 | $110 |
| LEO Pharma Inc. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
Products named: TREMFYA, DUPIXENT, OPZELURA, ILUMYA, RINVOQ, Winlevi, SKYRIZI, EBGLYSS.
Industry payments across PA — which companies pay providers there.
